Thursday, July 20, 2023 9:11:06 PM
I asked Chap GPT About BioAdaptives Inc. Partnerships? This was its response to my question:
BioAdaptives Inc. is a company that manufactures and distributes natural plant- and algal-based products that improve health and wellness for humans and animals 1. According to the recent news, BioAdaptives Inc. has entered into or announced the following partnerships:
A non-exclusive license agreement with LY Research Corporation to market a patented resveratrol product (patent US # 6,855,353) for animals and humans 2. The product is a liposome preparation that improves the bioavailability of resveratrol, a natural compound that has anti-aging, anti-inflammatory, anti-cancer, and cardiovascular benefits 2.
An exclusive marketing agreement with Flying C Bar Ranch (FCBR) Therapy Division to market its LiveStock Impact line of performance equine and pet supplements 3. The products are designed to enhance the health, vitality, and performance of horses and dogs by providing natural nutrients and antioxidants 3.
A second non-exclusive license agreement with LY Research Corporation to market a patented product (Patent # US 9,622,970 B2 ) for eye health due to myopia and presbyopia 4. The product is a liposome and sustained release polymeric micelles preparation that improves the solubility of lutein, a natural pigment that protects the eyes from oxidative stress and blue light damage 4.
A letter of intent with inventor Thomas J. Mohr to acquire rights to his U.S. Patent 9,783,432B, which covers technology used in enhancing the capability of water to hold significantly larger amounts of oxygen 5. The technology produces stable oxygenated water that provides a prolonged benefit following ingestion 5.
You can find more information about BioAdaptives Inc. and its products on its website . 😊
: https://bioadaptives.com/
BioAdaptives Inc. is a company that manufactures and distributes natural plant- and algal-based products that improve health and wellness for humans and animals 1. According to the recent news, BioAdaptives Inc. has entered into or announced the following partnerships:
A non-exclusive license agreement with LY Research Corporation to market a patented resveratrol product (patent US # 6,855,353) for animals and humans 2. The product is a liposome preparation that improves the bioavailability of resveratrol, a natural compound that has anti-aging, anti-inflammatory, anti-cancer, and cardiovascular benefits 2.
An exclusive marketing agreement with Flying C Bar Ranch (FCBR) Therapy Division to market its LiveStock Impact line of performance equine and pet supplements 3. The products are designed to enhance the health, vitality, and performance of horses and dogs by providing natural nutrients and antioxidants 3.
A second non-exclusive license agreement with LY Research Corporation to market a patented product (Patent # US 9,622,970 B2 ) for eye health due to myopia and presbyopia 4. The product is a liposome and sustained release polymeric micelles preparation that improves the solubility of lutein, a natural pigment that protects the eyes from oxidative stress and blue light damage 4.
A letter of intent with inventor Thomas J. Mohr to acquire rights to his U.S. Patent 9,783,432B, which covers technology used in enhancing the capability of water to hold significantly larger amounts of oxygen 5. The technology produces stable oxygenated water that provides a prolonged benefit following ingestion 5.
You can find more information about BioAdaptives Inc. and its products on its website . 😊
: https://bioadaptives.com/
Bullish
Recent BDPT News
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 02:45:46 AM
- BioAdaptives® Announces Commercial Launch of MyndMed™ Following Successful Pilot Testing • GlobeNewswire Inc. • 10/07/2025 03:48:03 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2025 07:16:01 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/13/2025 08:05:36 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 04/15/2025 09:20:25 PM

